Us Bancorp \De\ Macrogenics Inc Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Macrogenics Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 6,707 shares of MGNX stock, worth $21,663. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,707

Previous 754 789.52%

Holding current value

$21,663

Previous $3,000 633.33%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$3.0 - $5.55 $17,859 - $33,039	5,953 Added 789.52%	6,707 $22,000
Q2 2024 Aug 06, 2024	BUY	$3.31 - $18.51 $2,121 - $11,864	641 Added 567.26%	754 $3,000
Q1 2024 May 07, 2024	BUY	$9.77 - $21.47 $1,104 - $2,426	113 New	113 $1,000
Q1 2023 May 09, 2023	BUY	$4.82 - $7.24 $872 - $1,310	181 Added 7.8%	2,503 $17,000
Q4 2022 Feb 13, 2023	BUY	$3.34 - $6.98 $7,755 - $16,207	2,322 New	2,322 $15,000
Q2 2022 Aug 01, 2022	SELL	$2.25 - $9.99 $3,888 - $17,262	-1,728 Reduced 97.46%	45 $0
Q1 2022 May 11, 2022	BUY	$8.12 - $16.9 $14,274 - $29,710	1,758 Added 11720.0%	1,773 $16,000
Q4 2021 Feb 11, 2022	SELL	$15.91 - $21.88 $1,797 - $2,472	-113 Reduced 88.28%	15 $0
Q3 2021 Nov 10, 2021	SELL	$19.74 - $28.7 $2,112 - $3,070	-107 Reduced 45.53%	128 $3,000
Q4 2020 Feb 04, 2021	BUY	$19.41 - $26.0 $446 - $598	23 Added 10.85%	235 $5,000
Q3 2020 Nov 10, 2020	BUY	$24.69 - $31.6 $4,789 - $6,130	194 Added 1077.78%	212 $5,000
Q2 2020 Aug 07, 2020	SELL	$5.2 - $29.12 $2,334 - $13,074	-449 Reduced 96.15%	18 $1,000
Q1 2020 May 13, 2020	SELL	$4.28 - $12.11 $1,716 - $4,856	-401 Reduced 46.2%	467 $3,000
Q4 2019 Feb 04, 2020	BUY	$7.95 - $12.27 $5,191 - $8,012	653 Added 303.72%	868 $9,000
Q3 2019 Nov 08, 2019	BUY	$12.44 - $17.48 $2,674 - $3,758	215 New	215 $3,000
Q2 2019 Aug 13, 2019	SELL	$14.51 - $19.71 $1,189 - $1,616	-82 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$11.11 - $25.6 $777 - $1,792	70 Added 583.33%	82 $1,000
Q4 2018 Feb 13, 2019	SELL	$11.75 - $21.42 $5,228 - $9,531	-445 Reduced 97.37%	12 $0
Q2 2018 Aug 08, 2018	SELL	$19.78 - $24.67 $4,846 - $6,044	-245 Reduced 34.9%	457 $9,000
Q1 2018 May 08, 2018	BUY	$18.89 - $32.46 $2,455 - $4,219	130 Added 22.73%	702 $18,000
Q4 2017 Feb 02, 2018	BUY	$16.19 - $20.3 $9,260 - $11,611	572	572 $11,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $199M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account